|
Mischer Neuroscience Institute The Restorative Neurology & Neurosurgery Center at the Mischer Neuroscience Institute works to improve or restore the functional capability of patients suffering from neurological disorders, such as epilepsy or Parkinson’s disease and dramatically improve the quality of patients’ lives.Under the direction of Jeremy Slater, M.D., the epilepsy Houston program at the Mischer Neuroscience Institute is the leading program in the southwestern United States for diagnosing and treating patients of all ages with seizures and epilepsy and the only Level IV National Association of Epilepsy Centers-certified program in Houston. Each year, our top-ranked program diagnoses and treats more than 350 pediatric and adult inpatients in Memorial Hermann-Texas Medical Center’s Epilepsy Monitoring Unit (EMU), the largest unit in Houston. Our EMU is one of only a few inpatient units in the country with the unique capability of simultaneously performing electroencephalography and polysomnography. We brought the first clinical Magnetoencephalography (MEG) sensor to Houston in 1997. We are a national leader in combining the use of MEG and functional MRI in patient evaluations. MEG provides epileptologists and neurosurgeons with data that help locate the source of seizures and minimize operative risk in patients with epilepsy or brain lesions. Mischer Neuroscience Institute was the first in the region to perform vagus nerve stimulation, and we remain the No. 1 program in the United States in number of vagal nerve stimulators implanted in epilepsy patients. Our surgeons also perform the largest number of epilepsy surgeries on pediatric and adult patients in Houston. The movement disorders program, led by Mya Schiess, M.D., uses the latest medications and interventional methods to manage Parkinson's disease, atypical Parkinson syndromes, dystonia, tremor states, ataxia and other inherited and acquired neurodegenerative diseases. We have an active deep brain stimulation program for Parkinson’s tremor and dystonia patients and also use innovative strategies for the treatment of spasticity, or abnormal tone, especially in the post-stroke, multiple sclerosis, brain and spinal cord trauma patients. We have been innovators in the use of intrathecal baclofen, botulinum toxin and surgery to restore patients’ normal tone and motor function. Patients with cognitive disorders (dementia) are diagnosed by our experienced clinicians since appropriate treatment can reverse the damage in some dementia illnesses. We participate in clinical trials of new therapies for Alzheimer’s and other currently incurable neurodegenerative conditions, and have active research programs that bring new therapies from the laboratory for clinical testing. Conditions Treated - Alzheimer’s disease
- Ataxias/cerebellar disorders
- Cerebral palsy
- Cortical and subcortical dementias
- Epilepsy
- Essential tremor/tremor states
- Gait disorders
- Generalized and focal dystonias
- Generalized and partial seizures
- Huntington’s chorea
- Parkinson’s disease
- Spasticity management
- Spinocerebellar ataxias (SCA)
- Wilson’s disease
|